David Crosiers

2.0k total citations
32 papers, 523 citations indexed

About

David Crosiers is a scholar working on Neurology, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, David Crosiers has authored 32 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Neurology, 11 papers in Cognitive Neuroscience and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in David Crosiers's work include Parkinson's Disease Mechanisms and Treatments (21 papers), Neurological disorders and treatments (9 papers) and Restless Legs Syndrome Research (5 papers). David Crosiers is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (21 papers), Neurological disorders and treatments (9 papers) and Restless Legs Syndrome Research (5 papers). David Crosiers collaborates with scholars based in Belgium, Netherlands and Ethiopia. David Crosiers's co-authors include Patrick Cras, Christine Van Broeckhoven, Jessie Theuns, Barbara Pickut, Sebastiaan Engelborghs, Peter Paul De Deyn, Ellen Corsmit, Bram Meeus, Maria Mattheijssens and Ilse De Volder and has published in prestigious journals such as Acta Neuropathologica, Neurobiology of Aging and Movement Disorders.

In The Last Decade

David Crosiers

28 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Crosiers Belgium 14 391 118 104 96 96 32 523
José Matías Arbelo Spain 12 485 1.2× 78 0.7× 143 1.4× 142 1.5× 90 0.9× 20 623
K. Lohmann-Hedrich Germany 9 458 1.2× 80 0.7× 229 2.2× 134 1.4× 117 1.2× 9 576
Susanne Steinlechner Germany 10 350 0.9× 47 0.4× 183 1.8× 81 0.8× 65 0.7× 18 464
Celia van der Merwe South Africa 11 148 0.4× 69 0.6× 93 0.9× 125 1.3× 30 0.3× 16 371
Christina Thompson United States 9 629 1.6× 246 2.1× 279 2.7× 139 1.4× 144 1.5× 11 753
D. G. Healy United Kingdom 9 365 0.9× 67 0.6× 181 1.7× 76 0.8× 88 0.9× 15 465
L. Capus Italy 12 439 1.1× 138 1.2× 166 1.6× 38 0.4× 106 1.1× 16 587
Maria De Risi Italy 10 83 0.2× 138 1.2× 75 0.7× 100 1.0× 41 0.4× 14 342
Jens Ebentheuer Germany 13 832 2.1× 148 1.3× 182 1.8× 128 1.3× 127 1.3× 15 983
Thora Lohnau Germany 15 497 1.3× 84 0.7× 295 2.8× 219 2.3× 80 0.8× 16 709

Countries citing papers authored by David Crosiers

Since Specialization
Citations

This map shows the geographic impact of David Crosiers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Crosiers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Crosiers more than expected).

Fields of papers citing papers by David Crosiers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Crosiers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Crosiers. The network helps show where David Crosiers may publish in the future.

Co-authorship network of co-authors of David Crosiers

This figure shows the co-authorship network connecting the top 25 collaborators of David Crosiers. A scholar is included among the top collaborators of David Crosiers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Crosiers. David Crosiers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schil, Kristof Van, Tine Deconinck, Katrien Storm, et al.. (2025). TBP Repeat Expansion Analysis in Patients Carrying Heterozygous STUB1 Variants. Movement Disorders. 40(5). 980–985.
2.
Volder, Ilse De, Johan Verbraecken, Angelique Pijpers, et al.. (2025). Novel technologies for REM sleep behavior disorder detection for home screening in Parkinson’s disease and related alpha-synucleinopathies. npj Parkinson s Disease. 11(1). 196–196.
3.
Hertogh, Willem De, et al.. (2024). The effectiveness of physiotherapy for patients with isolated cervical dystonia: an updated systematic review and meta-analysis. BMC Neurology. 24(1). 53–53. 3 indexed citations
4.
Dekeyzer, Sven, et al.. (2024). Orthostatic tremor as possible presenting sign of progressive supranuclear palsy. Clinical Parkinsonism & Related Disorders. 11. 100275–100275.
5.
6.
Volder, Ilse De, et al.. (2022). Impaired bed mobility in prediagnostic and de novo Parkinson's disease. Parkinsonism & Related Disorders. 98. 47–52. 4 indexed citations
7.
Volder, Ilse De, et al.. (2022). Polysomnographic Predictors of Sleep, Motor, and Cognitive Dysfunction Progression in Parkinson’s Disease. Current Neurology and Neuroscience Reports. 22(10). 657–674. 12 indexed citations
8.
Volder, Ilse De, et al.. (2021). REM sleep without atonia and nocturnal body position in prediagnostic Parkinson's disease. Sleep Medicine. 84. 308–316. 7 indexed citations
9.
Philtjens, Stéphanie, David Crosiers, Anne Sieben, et al.. (2021). Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson’s disease. Acta Neuropathologica Communications. 9(1). 25–25. 28 indexed citations
10.
Viaene, Mineke, et al.. (2019). REM sleep without atonia and the relation with Lewy body disease. Parkinsonism & Related Disorders. 67. 90–98. 19 indexed citations
11.
Viaene, Mineke, et al.. (2019). Frequency and characteristic features of REM sleep without atonia. Clinical Neurophysiology. 130(10). 1825–1832. 7 indexed citations
12.
Crosiers, David, Aline Verstraeten, Sebastiaan Engelborghs, et al.. (2016). Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson’s disease and increase susceptibility to dementia in a Flanders-Belgian cohort. Neuroscience Letters. 629. 160–164. 20 indexed citations
13.
Crosiers, David, et al.. (2014). Impulse control disorders in Parkinson’s disease: an overview from neurobiology to treatment. Journal of Neurology. 262(1). 7–20. 18 indexed citations
14.
Verstraeten, Aline, David Crosiers, Bram Meeus, et al.. (2012). Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population. Neurobiology of Aging. 33(8). 1844.e11–1844.e13. 16 indexed citations
15.
Theuns, Jessie, David Crosiers, Luc Debaene, et al.. (2012). Guanosine triphosphate cyclohydrolase 1 promoter deletion causes dopa‐responsive dystonia. Movement Disorders. 27(11). 1451–1456. 8 indexed citations
16.
Meeus, Bram, Aline Verstraeten, David Crosiers, et al.. (2011). DLB and PDD: a role for mutations in dementia and Parkinson disease genes?. Neurobiology of Aging. 33(3). 629.e5–629.e18. 57 indexed citations
17.
Meeus, Bram, Aline Verstraeten, Karen Nuytemans, et al.. (2010). Dementia with Lewy Bodies: A Role for Dementia and Parkinson's Disease Genes?. Movement Disorders. 25. 1 indexed citations
18.
Meeus, Bram, Karen Nuytemans, David Crosiers, et al.. (2010). Comprehensive Genetic and Mutation Analysis of Familial Dementia with Lewy Bodies Linked to 2q35-q36. Journal of Alzheimer s Disease. 20(1). 197–205. 9 indexed citations
19.
Nuytemans, Karen, Bram Meeus, David Crosiers, et al.. (2009). Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population. Human Mutation. 30(7). 1054–1061. 46 indexed citations
20.
Meeus, Bram, Karen Nuytemans, David Crosiers, et al.. (2009). GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population. Neurobiology of Aging. 32(2). 308–312. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Matías Arbelo Breakdown of academic impact, for papers by K. Lohmann-Hedrich Breakdown of academic impact, for papers by Susanne Steinlechner Breakdown of academic impact, for papers by Celia van der Merwe Breakdown of academic impact, for papers by Christina Thompson Breakdown of academic impact, for papers by D. G. Healy Breakdown of academic impact, for papers by L. Capus Breakdown of academic impact, for papers by Maria De Risi Breakdown of academic impact, for papers by Jens Ebentheuer Breakdown of academic impact, for papers by Thora Lohnau
Rankless by CCL
2026